TY - JOUR
T1 - Frequency and Predictors of Analgesic Prescribing in U.S. Nursing Home Residents with Persistent Pain
AU - Fain, Kevin M.
AU - Alexander, G. Caleb
AU - Dore, David D.
AU - Segal, Jodi B.
AU - Zullo, Andrew R.
AU - Castillo-Salgado, Carlos
N1 - Funding Information:
Dr. Fain was supported as a Sommer Scholar at the Johns Hopkins University Bloomberg School of Public Health during the time of this study. Dr. Alexander is supported by the Agency for Healthcare Research and Quality (RO1 HS0189960) and the National Heart, Lung, and Blood Institute (R01 HL107345). Conflict of Interest: None. Author Contributions: Study concept and design: Fain, Castillo, Alexander, Dore, Segal. Acquisition of data: Fain, Dore. Statistical analysis: Fain, Dore, Zullo. Drafting initial article: Fain. Revising and approving final article version: all authors. Sponsor's Role: The funding sources had no role in the design or conduct of the study, analysis or interpretation of the data, or preparation or final approval of the manuscript before publication.
Publisher Copyright:
© 2016, Copyright the Authors Journal compilation © 2016, The American Geriatrics Society
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Objectives: To quantify prescription analgesic use of elderly nursing home (NH) residents with persistent noncancer pain and to identify individual and facility traits associated with no treatment. Design: Cross-sectional study. Setting: Linked Minimum Data Set (MDS) assessments; Online Survey, Certification and Reporting (OSCAR) records; and Medicare Part D claims. Participants: Individuals aged 65 and older with persistent noncancer pain were identified from a cross-section of all long-stay U.S. NH residents with an MDS assessment and Medicare Part D enrollment in 2008, excluding those who were terminally ill, those with Alzheimer's disease, and those with the most-severe cognitive impairment. Measurements: Residents with moderate to severe daily pain on consecutive assessments at least 90 days apart constituted the cohort with persistent pain. Part D dispensing for an opioid or nonsteroidal anti-inflammatory drug (NSAID) within 30 days of persistent pain onset was identified. Information on resident and facility characteristics was obtained from MDS and OSCAR records. Associations between resident and facility attributes and pain treatment were estimated using multilevel mixed-effects logistic regression analyses. Results: Of the study sample of 18,526 residents with persistent pain, 3,094 (16.7%) did not receive prescription analgesics, 12,815 (69.2%) received a prescription opioid, 485 (2.6%) received a prescription NSAID, and 2,132 (11.5%) received a prescription opioid and NSAID. After adjusting for potentially confounding covariates, residents who were older (≥95, odds ratio (OR) = 2.06, 95% confidence interval (CI) = 1.70–2.49), more cognitively impaired (moderately severe cognitive impairment, OR = 2.12, 95% CI = 1.71–2.62), or black (OR = 1.20, 95% CI = 1.03–1.39) or Asian (OR = 1.97, 95% CI = 1.22–3.20) were less likely to receive a prescription analgesic. Conclusion: Through 2008, pain remained undertreated in NHs, especially in certain subpopulations, including cognitively impaired and older residents. Changes in pain management practice and policies may be necessary to target these vulnerable residents.
AB - Objectives: To quantify prescription analgesic use of elderly nursing home (NH) residents with persistent noncancer pain and to identify individual and facility traits associated with no treatment. Design: Cross-sectional study. Setting: Linked Minimum Data Set (MDS) assessments; Online Survey, Certification and Reporting (OSCAR) records; and Medicare Part D claims. Participants: Individuals aged 65 and older with persistent noncancer pain were identified from a cross-section of all long-stay U.S. NH residents with an MDS assessment and Medicare Part D enrollment in 2008, excluding those who were terminally ill, those with Alzheimer's disease, and those with the most-severe cognitive impairment. Measurements: Residents with moderate to severe daily pain on consecutive assessments at least 90 days apart constituted the cohort with persistent pain. Part D dispensing for an opioid or nonsteroidal anti-inflammatory drug (NSAID) within 30 days of persistent pain onset was identified. Information on resident and facility characteristics was obtained from MDS and OSCAR records. Associations between resident and facility attributes and pain treatment were estimated using multilevel mixed-effects logistic regression analyses. Results: Of the study sample of 18,526 residents with persistent pain, 3,094 (16.7%) did not receive prescription analgesics, 12,815 (69.2%) received a prescription opioid, 485 (2.6%) received a prescription NSAID, and 2,132 (11.5%) received a prescription opioid and NSAID. After adjusting for potentially confounding covariates, residents who were older (≥95, odds ratio (OR) = 2.06, 95% confidence interval (CI) = 1.70–2.49), more cognitively impaired (moderately severe cognitive impairment, OR = 2.12, 95% CI = 1.71–2.62), or black (OR = 1.20, 95% CI = 1.03–1.39) or Asian (OR = 1.97, 95% CI = 1.22–3.20) were less likely to receive a prescription analgesic. Conclusion: Through 2008, pain remained undertreated in NHs, especially in certain subpopulations, including cognitively impaired and older residents. Changes in pain management practice and policies may be necessary to target these vulnerable residents.
KW - health disparities
KW - nursing homes
KW - persistent pain
KW - prescription opioids
UR - http://www.scopus.com/inward/record.url?scp=84999791777&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84999791777&partnerID=8YFLogxK
U2 - 10.1111/jgs.14512
DO - 10.1111/jgs.14512
M3 - Article
C2 - 28198563
AN - SCOPUS:84999791777
VL - 65
SP - 286
EP - 293
JO - Journal of the American Geriatrics Society
JF - Journal of the American Geriatrics Society
SN - 0002-8614
IS - 2
ER -